Tang Xiajing   M.D., Ph.D.

Academic Rank:Chief Physician
Clinical / Research Interests
Pediatric ophthalmology, strabismus
Professional Appointments

Member, Chinese Strabismus and Pediatric Ophthalmology Association, 2018-present

Publications

Tang XJ, Lou LX, Xu YF, et al. Socioeconomic inequality in the global burden of refraction disorders: results from the Global Burden of Diseases Study 2017, Acta Ophthalmol. 2020, Online ahead of print.

Tang XJ,Ping XY,Luo CQ, et al. Dystrophia canthorum in Waardenburg syndrome with a novel MITF mutation.Int J Ophthalmol 2020;13(7):1054-1059.

Tang XJ, Shentu XC, Tang YL, et al. The impact of GJA3 SNPs on susceptibility to age-related cataract, Int J Ophthalmol. 2019 ;12(6):1008-1011.

Shentu XC, Ping XY, Cheng YL, Zhang X, Tang YL, Tang XJ*. Hydrogen peroxide-induced apoptosis of human lens epithelial cells is inhibited by parthenolide, Int J Ophthalmol. 2018;11(1):12-17.

Su ZA, Tang XJ*, Zhang LX, et al. Comparison of outcomes between overlapping-spot and single-spot photodynamic therapy for circumscribed choroidal hemangioma, Int J Ophthalmol. 2014;7(1):66-70.

Tang XJ, Yao K, Zhang L, et al. Honokiol inhibits H(2)O(2)-induced apoptosis in human lens epithelial cells via inhibition of the mitogen-activated protein kinase and Akt pathways, Eur J Pharmacol. 2011;650(1):72-8.

Yao K, Tang XJ, Shentu XC, et al. Progressive polymorphic congenital cataract caused by a CRYBB2 mutation in a Chinese family, Molecular Vision. 2005; 11(89-92) : ‏ 758-763.

Current Program

Mechanisms of Crb Complex Regulating Cell Movement and Adhesion in Lens. Funding Source: National Natural Science Foundation of China.

© 2022 Zhejiang University Eye Hospital. All rights reserved.